| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |